TrialBMC cancer2020

Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study.

Suayib Yalcin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.